Therefore, human whole cell granulocyte macrophage colony-stimulating factor (GM-CSF) secreting pancreatic cancer vaccines (GVAX) are being developed to increase PD-L1 expression and enhance tumour antigen-specific interferon-γ producing T cells in peripheral lymphocytes. Here, CSF2 is linked to neoplasm.